Promega v. Roche
This article was originally published in The Gray Sheet
Executive Summary
European Patent Office (EPO) in Munich revokes Roche's biotechnology patent '017, which covers components critical to DNA analysis used in polymerase chain reaction (PCR) and gene sequencing, Promega announces May 31. Madison, Wisconsin-based firm, along with BD Corp., New England BioLabs and Bioline, presented data to EPO showing that others had purified the Taq DNA polymerase first and that the recombinant Taq gene was obviously based on prior art. EPO's decision to revoke the patent is consistent with 1999 San Francisco federal court ruling that Roche committed eight separate acts of fraud in obtaining its '818 patent (1"The Gray Sheet" Dec. 13, 1999, p. 16)
You may also be interested in...
Roche To Appeal Native Taq Ruling To Defend Scientific Integrity
Roche Molecular Systems and parent company Hoffman-La Roche intend to appeal a Dec. 7 San Francisco federal district court ruling that the firm's native Taq polymerase patent is "unenforceable" because of inequitable conduct during Cetus Corp.' s patent application process in 1986, Roche said Dec. 8.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.